145 related articles for article (PubMed ID: 37999810)
1. Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
Langenbecks Arch Surg; 2023 Nov; 408(1):445. PubMed ID: 37999810
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer.
Kainuma O; Miura F; Furukawa D; Yamamoto H; Cho A; Sano K; Nakagohri T; Asano T
J Hepatobiliary Pancreat Sci; 2015 Nov; 22(11):789-94. PubMed ID: 26234468
[TBL] [Abstract][Full Text] [Related]
3. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer.
Lee HS; Lee SH; Roh YH; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Chemotherapy; 2016; 61(3):152-8. PubMed ID: 26788726
[TBL] [Abstract][Full Text] [Related]
5. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
Jang JY; Kim SW; Park DJ; Ahn YJ; Yoon YS; Choi MG; Suh KS; Lee KU; Park YH
Ann Surg; 2005 Jan; 241(1):77-84. PubMed ID: 15621994
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
Ann Surg; 2009 Dec; 250(6):950-6. PubMed ID: 19953713
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer.
Mori S; Aoki T; Shiraki T; Shimizu T; Yamaguchi T; Park KH; Matsumoto T; Sakuraoka Y; Iso Y; Kubota K
Anticancer Res; 2021 Oct; 41(10):5231-5240. PubMed ID: 34593476
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome.
Yokomizo H; Yamane T; Hirata T; Hifumi M; Kawaguchi T; Fukuda S
Ann Surg Oncol; 2007 Apr; 14(4):1366-73. PubMed ID: 17260109
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
[TBL] [Abstract][Full Text] [Related]
10. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
11. The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis.
Hamura R; Haruki K; Taniai T; Yanagaki M; Shirai Y; Furukawa K; Usuba T; Fujioka S; Okamoto T; Nakabayashi Y; Uwagawa T; Ikegami T
Int J Clin Oncol; 2022 Jul; 27(7):1188-1195. PubMed ID: 35426581
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
[TBL] [Abstract][Full Text] [Related]
14. The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy.
Kishi Y; Shimada K; Nara S; Esaki M; Kosuge T
Langenbecks Arch Surg; 2016 Jun; 401(4):503-11. PubMed ID: 27074727
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
16. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction.
Ferrero A; Lo Tesoriere R; Viganò L; Caggiano L; Sgotto E; Capussotti L
World J Surg; 2009 Feb; 33(2):318-25. PubMed ID: 19020929
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Sui K; Shimada Y; Iiyama T
Anticancer Res; 2017 Dec; 37(12):7049-7056. PubMed ID: 29187494
[TBL] [Abstract][Full Text] [Related]
18. Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients.
Im JH; Seong J; Lee IJ; Park JS; Yoon DS; Kim KS; Lee WJ; Park KR
Cancer Res Treat; 2016 Apr; 48(2):583-95. PubMed ID: 26323644
[TBL] [Abstract][Full Text] [Related]
19. A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
Itano O; Takemura Y; Kishida N; Tamagawa E; Shinozaki H; Ikeda K; Urakami H; Ei S; Hayatsu S; Suzuki K; Sakuragawa T; Ishii M; Shito M; Aiura K; Fujisaki H; Takano K; Matsui J; Minagawa T; Shinoda M; Kitago M; Abe Y; Yagi H; Oshima G; Hori S; Kitagawa Y
BMC Cancer; 2020 Jul; 20(1):688. PubMed ID: 32703191
[TBL] [Abstract][Full Text] [Related]
20. A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer.
Yamanaka K; Hatano E; Kanai M; Tanaka S; Yamamoto K; Narita M; Nagata H; Ishii T; Machimoto T; Taura K; Uemoto S
Int J Clin Oncol; 2014; 19(3):485-9. PubMed ID: 23765238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
